Inventor · disambiguated record
David Powers
Also filed as: POWERS DAVID · POWERS DAVID B · POWERS DAVID BRIAN
31 granted patents·4 pending applications·458 citations·filing 1992–2018
97Inventor score
Files withFACET BIOTECH CORP6UNIV RUTGERS5ABBVIE BIOTHERAPEUTICS INC4ABBOTT BIOTHERAPEUTICS CORP3HARDING FIONA A3
Top patents by PatentIndex Score
35 records- 0193US7709610B2Therapeutic use of anti-CS1 antibodiesFACET BIOTECH CORP·Filed 2004·Granted May 4, 2010·40 cites·26 claims
- 0293US5411873AProcess for producing heterologous polypeptidesGENENCOR INC·Filed 1992·Granted May 2, 1995·60 cites·22 claims
- 0393US5376544AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1992·Granted Dec 27, 1994·52 cites·1 claims
- 0492US10233258B2Bispecific binding proteins that bind CD40 and mesothelinABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Mar 19, 2019·16 cites·10 claims
- 0591US9079953B2Anti-VEGF antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jul 14, 2015·23 cites·11 claims
- 0691US7674883B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Mar 9, 2010·6 cites·14 claims
- 0791US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 0890US8937159B2Anti-HER2 antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jan 20, 2015·12 cites·16 claims
- 0990US8461306B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted Jun 11, 2013·10 cites·19 claims
- 1088US8633139B2Methods of screening complex protein libraries to identify altered propertiesDUBRIDGE ROBERT·Filed 2008·Granted Jan 21, 2014·12 cites·20 claims
- 1188US8444980B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted May 21, 2013·8 cites·40 claims
- 1288US8349330B2Therapeutic use of anti-CS1 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2011·Granted Jan 8, 2013·8 cites·16 claims
- 1388US7285268B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2004·Granted Oct 23, 2007·18 cites·10 claims
- 1488US7276589B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·23 cites·9 claims
- 1587US9315573B2Anti-TNF-alpha antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 19, 2016·9 cites·36 claims
- 1687US8436146B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted May 7, 2013·7 cites·18 claims
- 1784US7824678B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Nov 2, 2010·4 cites·9 claims
- 1882US8658175B2Anti-EGFR antibodies and their usesDUBRIDGE ROBERT B·Filed 2010·Granted Feb 25, 2014·13 cites·41 claims
- 1981US8017116B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Sep 13, 2011·3 cites·4 claims
- 2081US7785816B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Aug 31, 2010·2 cites·4 claims
- 2177US5795761AMutants of 2,5-diketo-D-gluconic acid (2,5-DKG) reductase AUNIV RUTGERS·Filed 1996·Granted Aug 18, 1998·42 cites·12 claims
- 2270US5583025AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1994·Granted Dec 10, 1996·26 cites·9 claims
- 2369US8722860B2Anti-TNF-α antibodies and their usesHARDING FIONA A·Filed 2010·Granted May 13, 2014·1 cites·36 claims
- 2469US5939315AProcess for producing heterologous polypeptidesFiled 1995·Granted Aug 17, 1999·16 cites·14 claims
- 2569US5912161AEnzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1996·Granted Jun 15, 1999·18 cites·16 claims
- 2666US8309084B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisRAMAKRISHNAN VANITHA·Filed 2011·Granted Nov 13, 2012·1 cites·6 claims
- 2764US7879987B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Feb 1, 2011·0 cites·11 claims
- 2864US7776585B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Aug 17, 2010·0 cites·11 claims
- 2963US7897148B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 3056US2015051081A1Method of screening complex protein libraries to identify altered propertiesABBVIE BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3152US8257708B2Antibodies against cancer antigen TMEFF2 and uses thereofBHASKAR VINAY·Filed 2010·Granted Sep 4, 2012·0 cites·21 claims
- 3249US2020085996A1Resorbable material dispenser and method of usePOWERS DAVID B·Filed 2018·Application pending·0 cites
- 3346US2017342169A1Bispecific binding proteinsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3441US2008227131A1Signalling Assay and Cell LineGE HEALTHCARE UK LTD·Filed 2006·Application pending·0 cites
- 3539US7256027B1Enzymes for the production of 2-keto-L-gulonic acidUNIV RUTGERS·Filed 1999·Granted Aug 14, 2007·1 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →